3D Cell Culture - Global Strategic Business Report

The global market for 3D Cell Culture is estimated at US$1.6 Billion in 2023 and is projected to reach US$3.9 Billion by 2030, growing at a CAGR of 13.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the 3D cell culture market is driven by several factors, including the escalating demand for more accurate and reliable drug screening methods and the rising need for personalized medicine solutions. Technological innovations that offer enhanced scalability, reproducibility, and automation of 3D culture systems are crucial in meeting these demands. Additionally, as the potential of 3D cell cultures in clinical applications becomes more evident, there is a growing interest from pharmaceutical companies and healthcare providers to invest in this technology.

Consumer behavior, particularly the increasing public and regulatory pressure to reduce animal testing in pharmaceutical and cosmetic industries, also plays a significant role in driving the adoption of 3D cultures. Moreover, the expanding applications of 3D cell cultures in cancer research, stem cell therapy, and tissue engineering continue to spur the development of new products and techniques in this field. These factors, combined with ongoing academic and commercial research collaborations, ensure a dynamic and expanding market, poised to address some of the most challenging issues in medical research and patient care.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Scaffold-based 3D Cell Culture segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of a 13.9%. The Scaffold-free 3D Cell Culture segment is also set to grow at 13.3% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $498.7 Million in 2023, and China, forecasted to grow at an impressive 14.9% CAGR to reach $248.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global 3D Cell Culture Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global 3D Cell Culture Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global 3D Cell Culture Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 38 Featured):

Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Corning, Inc.
Charles River Laboratories International, Inc.
BioTek Instruments, Inc.
F. Hoffmann-La Roche AG
AMS Biotechnology (Europe) Ltd. (amsbio)
BellBrook Labs
ABER Instruments Ltd.
Creative Biolabs
Elveflow
Emulate, Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
3D Cell Culture - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
3D Cell Culture Transforms Life Sciences Industry
3D Cell Culture: An Introduction
3D-Cell Culture Models
Benefits of 3D Cell Culture
Key 3D Cell Culture Formats
3D Cell Culture - Different Techniques
Scaffold-Based 3D Cell Culture
Polymeric Hard Scaffolds
Biological Scaffolds
Micropatterned Surface Microplates
Non-Scaffold Based 3D Cell Culture
Hanging Drop Microplates
Spheroid Microplates with Ultra-Low Attachment (ULA) coating
Microfluidic 3D Cell Culture
Expanding Applications Fuel Growth in the Global 3D Cell Culture Market
Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth
Scaffold-based 3D Cell Culture Products Dominate the Market
Cancer and Stem Cell Research Leads the Global Market
Competitive Scenario
Key Commercial 3D Cell Culture Devices
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Increasing Demand for 3D Cell Culture in Drug Discovery
Use of 3D Cell Culture for Regenerative Medicine
Organoids as Alternatives to Using Animals in Experiments
Use of 3D Cell Culture for Regenerative Medicine
Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges
Technological Advancements Promote 3D Cell Culture Market
Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures
3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
A Review of Research Efforts and Achievements of Companies and Universities
3D Tissue Culture: Growing Significance in Cancer Research
Cells Grown in 3D Change Cell Proliferation and Morphology
Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
Cells Grown in 3D Express Phenotypic Heterogeneity
Cells Grown in 3D Alter Cell Behavior and Gene Expression
Cells Grown in 3D Replicate the Tumor Microenvironment
Other Advantages of 3D Tissue Culture Models
New Dimension of Cell Culture: The Rise of Spheroid Culture Systems
Challenges
Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: World Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 3: World 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 6: World 13-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 9: World 13-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 12: World 13-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 15: World 13-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 18: World 13-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 21: World 13-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 24: World 13-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
TABLE 25: World 3D Cell Culture Market Analysis of Annual Sales in US$ Thousand for Years 2017 through 2030

III. MARKET ANALYSIS

UNITED STATES

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 28: USA 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 31: USA 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

CANADA

TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 34: Canada 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 37: Canada 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

JAPAN

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 40: Japan 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 41: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 43: Japan 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

CHINA

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 44: China Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 46: China 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 47: China Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 49: China 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

EUROPE

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 52: Europe 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 55: Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 58: Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

FRANCE

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 59: France Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 61: France 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 64: France 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

GERMANY

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 67: Germany 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 70: Germany 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

ITALY

TABLE 71: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 73: Italy 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 76: Italy 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

UNITED KINGDOM

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 79: UK 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 82: UK 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

REST OF EUROPE

TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 85: Rest of Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 88: Rest of Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

ASIA-PACIFIC

3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 91: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 94: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

REST OF WORLD

TABLE 95: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 97: Rest of World 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
TABLE 100: Rest of World 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

IV. COMPETITION

Companies Mentioned

Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Corning, Inc.
Charles River Laboratories International, Inc.
BioTek Instruments, Inc.
F. Hoffmann-La Roche AG
AMS Biotechnology (Europe) Ltd. (amsbio)
BellBrook Labs
ABER Instruments Ltd.
Creative Biolabs
Elveflow
Emulate, Inc.

Table Information

Report Attribute	Details
No. of Pages	150
Published	December 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 1.6 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.9 Billion
Compound Annual Growth Rate	13.9%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4875EUR$4,950USD£4,012GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9263EUR$9,405USD£7,623GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14626EUR$14,850USD£12,037GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 38 Featured):

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

3D Cell Culture Market Report: Trends, Forecast and Competitive Analysis to 2030

3D Cell Cultures: Technologies and Global Markets

3D Cell Culture - A Global Market Overview

3D Cell Culture Market - Global Outlook & Forecast 2024-2029

3D Cell Culture Technologies Patent Landscape Report and Forecast 2024-2032